Comments
Loading...

Akero Therapeutics Stock Guidance

AKRONASDAQ
Logo brought to you by Benzinga Data
$40.01
-1.52-3.66%
At close: -
$39.50
-0.51-1.27%
After Hours: 4:10 PM EDT
Q1 2025 Earnings were released on Mon May 12th, before the market open

Akero Therapeutics Stock Guidance | NASDAQ:AKRO | Benzinga

Akero Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
Akero Therapeutics Inc (AKRO) does not provide guidance data

FAQ

Q

What is the most recent guidance for Akero Therapeutics (AKRO)?

A

There have been no specific sales or earnings guidance reported for Akero Therapeutics in recent months.

Browse guidance and forecast on all stocks.

People Also Watch